Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics


November 26, 2009
165 Pages - SKU: RET2539906
License type:
Table of Contents Search inside this report Related Reports
US Personalized Cancer Genome Sequencing Marketrncos
5/1/2013 | published by: RNCOS
The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. “ US Personalized Cancer Genome Sequencing Market ” takes into account the Whole-Genome Sequencing services, which is one of the most  |  read more...
$1,200.00
Personalized Medicine Market Analysis
5/1/2013 | published by: RNCOS
Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as  |  read more...
$1,200.00
Genetic Testing Market Outlook to 2017
5/1/2013 | published by: RNCOS
Genetic Testing Market Outlook to 2017 provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page  |  read more...
$1,200.00
Gene Therapy in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Gene Therapy in Oncology Drug Pipeline Update 2013 There are today 120 companies plus partners developing 109 gene therapy drugs in 257 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated  |  read more...
$5,621.25
Global Chiral Technology Market 2012-2016
4/19/2013 | published by: Infiniti Research Limited
Global Chiral Technology Market 2012-2016 TechNavio's analysts forecast the Global Chiral Technology market to grow at a CAGR of 6.6 percent over the period 2012-2016. One of the key factors  |  read more...
$2,000.00
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts
2/28/2013 | published by: GlobalData
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is  |  read more...
$4,450.00
MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts
2/28/2013 | published by: GlobalData
MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is  |  read more...
$4,450.00
Pharmacogenomics Partnering Terms and Agreements
4/1/2013 | published by: Current Partnering
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a  |  read more...
$2,795.00
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
4/1/2013 | published by: BioInformant Worldwide, L.L.C.
OVERVIEW The cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood  |  read more...
$3,995.00
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts
2/28/2013 | published by: GlobalData
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer  |  read more...
$4,450.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Molecular Biology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!